Health Bulletin 9/March/2023

Here are the top health stories for the day:

900 NEET SS seats still vacant: Doctors demand another Mop-Up Round

Pointing out that more than 900 super-specialty seats are lying vacant even after the NEET SS Mop up round, the doctors under the umbrella of Federation of Resident Doctors' Association (FORDA) have recently urged the Medical Counselling Committee (MCC) to conduct another mop-up round for filling up the vacant seats.

Writing to the Directorate General of Health Services (DGHS), FORDA pointed out that NEET SS seats are a national asset and should not go vacant. With this, the association urged the DGHS for conducting another mop-up round "in the larger interest of students and citizens who stand to benefit immensely from having more super-specialty doctors in the country."

For more details, check out the link given below:

900 NEET SS Seats Still Vacant: Doctors Demand Another Mop-Up Round

Doctor shortage in Punjab: MBBS, MD Graduates to be recruited at govt hospitals

Referring to the shortage of specialist doctors in the State, the Health, Medical Education and Research minister Dr Balbir Singh clarified before the State Assembly that after completing the Post Graduate medical courses, the newly graduated specialist doctors will provide their services in the government hospitals.

Apart from this, the Health Minister of the State also pointed out how the previous government failed to ensure that PG medical graduates from government medical colleges provided their services to the government-run hospitals for a few years and how the bond penalty amount was also not recovered from them.

For more details, check out the link given below:

Doctor Shortage In Punjab: MBBS, MD Graduates To Be Recruited At Govt Hospitals

Orthopaedic surgeon guilty of medical negligence, liable to pay Rs 15 lakh compensation: Consumer Forum

Holding medical negligence by an orthopaedic surgeon during fracture surgery, the Nagpur-based Disputes Consumer Redressal Forum has granted compensation of Rs 15 lakh to a patient.

The patient filed a plea before the Forum asking for compensation of Rs 20 lakhs against the orthopaedic surgeon and the insurance company, which indemnified the doctor during treatment, alleging that the surgeon was negligent in discharging his duties.

For more details, check out the link given below:

Orthopedic Surgeon Guilty Of Medical Negligence, Liable To Pay Rs 15 Lakh Compensation: Consumer Forum

Post-COVID, chest pains may linger for up to a year, new study finds

Even patients with mild COVID-19 infections can suffer from health complications for months, even years, post infection. Nearly 19% of U.S. adults who had previously tested positive for COVID-19 report having “Long COVID,” where they experience signs and symptoms for four weeks or more after the initial phase of infection.

In an effort to quantify what Long COVID means now, and could mean in the future for these patients, researchers from Intermountain Health in Salt Lake City studied nearly 150,000 patients for cardiovascular symptoms.

They found that patients who tested positive for COVID-19 had higher rates of chest pain in the six months to a year after the infection.

Reference:

MEETING American College of Cardiology’s 72nd Annual Scientific Session Together With World Heart Federation’s World Congress of Cardiology

Indian pharma firms grew faster at 7 percent compared to 4 percent of MNCs in 2022: IQVIA

The Indian Pharmaceutical Market (IPM) has reflected growth of 7 percent in the year 2022 with overall IPM market size at Rs 1,93,838 crore Moving Annual Turnover (MAT), as per IQVIA.

As per the report, the growth in Sales Value was recorded at 7% (MAT), and Chronic TAs growth (9% MAT) outperformed Acute TAs growth (5% MAT) in 2022.

The relative performance of the Indian Pharma companies grew faster at 7% compared to MNCs which grew at 4% in 2022. Further, the number of new launches have increased by 2% to 3032 in 2022 as compared to 2021.

For more details, check out the link given below:

Indian Pharma Firms Grew Faster At 7 Percent Compared To 4 Percent Of MNCs In 2022: IQVIA